Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-25 @ 4:25 AM
NCT ID:
NCT00560820
Eligibility Criteria:
Inclusion criteria:
* Male or female patients ≥ 18 years of age without prior history of deferasirox treatment
* β-thalassemia patients receiving regular transfusions every 2-5 weeks
* Transfusion history of ≥ 20 units of packed red blood cells
Exclusion criteria:
* Abnormal renal function at baseline
* ALT greater than 5 x ULN at screening
* Patients with underlying cardiac disease requiring continuous iron chelation therapy
Other protocol-defined inclusion/exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00560820
Study Brief:
Protocol Section:
NCT00560820